Dambkowski Carl

Chief Medical OfficerApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Jan 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Option exercise(M)14K$22.86$321K231K
Jan 7, 2026Sell(S)15K$77.90$1.2M213K
Jan 7, 2026Sell(S)826$79.04$65K213K
Jan 7, 2026Sell(S)100$80.06$8K213K
Jan 7, 2026Sell(S)3K$77.13$228K228K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 7, 2026Option exercise(M)14K$0140K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-002574) within minutes of acceptance. Every field above traces to the original document. Verify it directly: